AACR Releases Cancer Disparities Progress Report 2026
Report features latest statistics, including promising signs of progress, and 10 compelling personal stories PHILADELPHIA – The American Association...
Search/Filter
Loading...
Emerging Frontiers in Oncology to Support AACR and Early-Career Investigators Through Annual Oncology Summit
PHILADELPHIA – The American Association for Cancer Research (AACR) today thanked Emerging Frontiers in Oncology (EFO) for its support...
American Association for Cancer Research Inaugurates New Leadership During AACR Annual Meeting 2026
Keith T. Flaherty, MD, FAACR, begins term as AACR President SAN DIEGO – The members of the American Association...
Robert H. Vonderheide, MD, DPhil, FAACR, Elected as American Association for Cancer Research President-Elect for 2026-2027
Five new AACR Board of Directors members elected PHILADELPHIA – The members of the American Association for Cancer Research...
AACR Announces Fellows of the AACR Academy Class of 2026
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected 2026 class of Fellows of...
AACR Releases Inaugural Pediatric Cancer Progress Report
More than 30 new drugs have been approved for pediatric cancer in the past 10 years, but progress has...
AACR Applauds Selection of Richard Pazdur, MD, as Director of the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Richard Pazdur, MD, on his appointment as Director...
AACR Congratulates Members Elected to the National Academy of Medicine
PHILADELPHIA – The American Association for Cancer Research (AACR) extends its sincerest congratulations to the nine AACR members who...
AACR Applauds Appointment of Anthony G. Letai, MD, PhD, as Director of the National Cancer Institute
PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Anthony G. Letai, MD, PhD, on his appointment...
AACR Cancer Progress Report Highlights Lifesaving Impact of Federal Investments in Cancer Research
FDA approved 20 new cancer drugs during the 12 months covered by the report, but challenges such as early-onset...